Systemic lupus erythematosus associated with moyamoya syndrome: A case report and literature review

Lupus

Volumn 22, Issue 6, 2013, Pages 629-633

  Wang, R ^a   Xu, Y ^a   Lv, R ^a   Chen, J ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b State Administration of Traditional Chinese Medicine   (China)

Author keywords

cerebral vascular hemorrhage; internal carotid artery occlusion; moyamoya syndrome; nephrotic syndrome; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOUBLE STRANDED DNA ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DECOMPRESSIVE CRANIECTOMY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MEMBRANOUS GLOMERULONEPHRITIS; MOYAMOYA DISEASE; NEPHROTIC SYNDROME; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

CEREBRAL VASCULAR HEMORRHAGE; INTERNAL CAROTID ARTERY OCCLUSION; MOYAMOYA SYNDROME; NEPHROTIC SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

CRANIOTOMY; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACRANIAL HEMORRHAGES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOYAMOYA DISEASE; NEPHROTIC SYNDROME; TACROLIMUS; YOUNG ADULT;

EID: 84878274009     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313485828     Document Type: Article

References (15)

1. Takeuchi K, Shimizu K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve. 1957 ; 9: 37-43
2. Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S. Prothrombotic disorders in children with moyamoya syndrome. Stroke. 2001 ; 32: 1786-1792
3. Matsuki Y, Kawakami M, Ishizuka T, et al. SLE and Sjögren's syndrome associated with unilateral moyamoya vessels in cerebral arteries. Scand J Rheumatol. 1997 ; 26: 392-394
4. Roubey RAS. Immunology of the antiphospholipid syndrome: Antibodies, antigens and autoimmune response. Thromb Haemost. 1999 ; 82: 656-661
5. Prelipcean V, Koch AE. Systemic lupus erythematosus associated with moyamoya disease case report and review of the literature. J Clin Rheumatol. 1998 ; 4: 328-332
6. El Ramahi KW, Al Rayes HM. Systemic lupus erythematosus associated with moyamoya syndrome. Lupus. 2000 ; 9: 632-636
7. Lee CM, Lee SY, Ryu SH, Lee SW, Park KW, Chung WT. Systemic lupus erythematosus associated with familial moyamoya disease. Korean J Intern Med. 2003 ; 18: 244-247
8. Jeong HC, Kim YJ, Yoon W, Joo SP, Lee SS, Park YW. Moyamoya syndrome associated with systemic lupus erythematosus. Lupus. 2008 ; 17: 679-682
9. Mok CC, Poon WL. Moyamoya phenomenon in systemic lupus erythematosus. Rheumatology (Oxford). 2011 ; 50: 1931-1931
10. Lin R, Xie Z, Zhang J, et al. Clinical and immunopathological features of Moyamoya disease. PLoS One. 2012 ; 7: e36386 - e36386
11. Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: Its clinical features and outcomes. Stroke. 2012 ; 43: 56-60
12. Freis JF, Holman HR. Systemic lupus erythematosus: A clinical analysis. Major Probl Intern Med. 1975 ; 6: v1 - v199
13. Koffler D, Carr RI, Agnello V, Fiezi T, Kunkel HG. Antibodies to polynucleotides: Distribution in human serums. Science. 1969 ; 166: 1648-1649
14. Andrew M, Monagle PT, Brooker L. Stroke. In: Andrew M, Monagle PT, Brooker L (eds) Thromboembolic complications during infancy and childhood. London, UK: Decker Inc, 2000, pp.201-230.
15. Spittler JF, Smektala K. Pharmacotherapy in moyamoya disease. Hokkaido Igaku Zasshi. 1990 ; 65: 235-240